Showing results (81-90 of 138) with videos related to

Sort By:
Pageof 14
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2021
Randomized Controlled Phase II Evaluation of Two Dose Levels of Bupropion Versus Placebo for Sexual Desire in Female Cancer Survivors: NRG-CC004Debra L Barton, Stephanie L Pugh, Patricia A Ganz, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2025
Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase III Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic AstrocytomaJessica L Fleming, Stephanie L Pugh, Susan M Chang, et al.
International Journal of Radiation Oncology, Biology, Physics|December 15, 2023
Impact of Apolipoprotein E Genotype on Neurocognitive Function in Patients With Brain Metastases: An Analysis of NRG Oncology's RTOG 0614Jeffrey S Wefel, Snehal Deshmukh, Paul D Brown, et al.
Gynecologic Oncology|July 2, 2023
Quality-adjusted survival in women with gynecologic malignancies receiving IMRT after surgery: A Ppatient Rreported Ooutcome study of NRG oncology's RTOG 1203Andre Konski, Snehal Deshmukh, Ann H Klopp, et al.
International Journal of Radiation Oncology, Biology, Physics|July 4, 2025
"Hope" Drives Quality of Life in Patients With Brain Metastases, But, the "Hope Center" Remains Elusive: An Analysis of NRG-CC003Benjamin W Corn, Rebecca Paulus, Vinai Gondi, et al.
Advances in Radiation Oncology|September 12, 2018
Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicitiesCanhua Xiao, Jennifer Moughan, Benjamin Movsas, et al.
The Prostate|July 21, 2025
Prognostic Impact of Lymph Node Yield in a Phase III Clinical Trial (NRG/RTOG 9601) of Prostate Cancer Patients Treated With Salvage Radiation Following ProstatectomyEmily Chan, Stephanie L Pugh, Jeffry P Simko, et al.
International Journal of Radiation Oncology, Biology, Physics|June 5, 2025
Long-Term Feeding Tube Use in Head and Neck Cancer Survivors-An Analysis of Patient- and Treatment-Related FactorsThomas J Galloway, Stephanie L Pugh, John A Ridge, et al.
The New England Journal of Medicine|April 7, 2016
Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade GliomaJan C Buckner, Edward G Shaw, Stephanie L Pugh, et al.
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical TrialEthan Basch, Stephanie L Pugh, Amylou C Dueck, et al.
Pageof 14